These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8382471)

  • 61. Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysis.
    Bouillon R; Verberckmoes R; Moor PD
    Kidney Int; 1975 Jun; 7(6):422-32. PubMed ID: 169419
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
    Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
    Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of hormone replacement therapy on CD4+ and CD8+ numbers, CD4+/CD8+ ratio, and immunoglobulin levels in hemodialysis patients.
    Dogan E; Erkoc R; Demir C; Sayarlioglu H; Dilek I; Sayarlioglu M
    Ren Fail; 2005; 27(4):421-4. PubMed ID: 16060130
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Naïve and central memory T-cell lymphopenia in end-stage renal disease.
    Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
    Kidney Int; 2006 Jul; 70(2):371-6. PubMed ID: 16738532
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.
    Kates DM; Sherrard DJ; Andress DL
    Am J Kidney Dis; 1997 Dec; 30(6):809-13. PubMed ID: 9398125
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Uremic restless legs syndrome (RLS) and sleep quality in patients with end-stage renal disease on hemodialysis: potential role of homocysteine and parathyroid hormone.
    Gade K; Blaschke S; Rodenbeck A; Becker A; Anderson-Schmidt H; Cohrs S
    Kidney Blood Press Res; 2013; 37(4-5):458-63. PubMed ID: 24247595
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared?
    Tzanno-Martins C; Futata E; Jorgetti V; Duarte AJ
    Clin Nephrol; 2000 Jul; 54(1):22-9. PubMed ID: 10939753
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Profound reversible CD4+ T lymphocytopenia in a severely uremic patient.
    Polsky FI; Dannemann B; Hemmert WH
    Am J Kidney Dis; 1994 Jul; 24(1):89-91. PubMed ID: 8023830
    [TBL] [Abstract][Full Text] [Related]  

  • 69. On the effect of magnesium on the PTH secretion in uremic patients on maintenance hemodialysis.
    Gonella M; Bonaguidi F; Buzzigoli G; v Bartolini ; Mariani G
    Nephron; 1981; 27(1):40-2. PubMed ID: 7219636
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Use of the dinitrochlorobenzene test in evaluation of cellular immunity in uremic patients].
    Giacchino F; Triolo G; Coppo R; Alloatti S; Quarello F; Rotunno M; Martini PF; Segoloni G; Piccoli G; Vercellone A
    Minerva Nefrol; 1979; 26(3):343-8. PubMed ID: 318059
    [No Abstract]   [Full Text] [Related]  

  • 71. Parathyroid hormone control survey to determine inter-method and inter-lab variations in Japan.
    Kakuta T; Kato H; Komaba H; Akizawa T;
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():50-5. PubMed ID: 21595853
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
    Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD
    Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone.
    McGonigle RJ; Fowler MB; Timmis AB; Weston MJ; Parsons V
    Nephron; 1984; 36(2):94-100. PubMed ID: 6229702
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.
    Fang L; Tang B; Hou D; Meng M; Xiong M; Yang J
    BMC Nephrol; 2015 Jun; 16():82. PubMed ID: 26058796
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Clinical, radiological and ultrasonic correlations in secondary hyperparathyroidism. Observations concerning 75 patients on dialysis].
    Giuseppetti GM; Giovagnoni A; Baldelli S; Macchini M; Bordoni E
    Radiol Med; 1986; 72(1-2):29-31. PubMed ID: 3515463
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Target range of PTH in uremia].
    Tahara H; Tabata T
    Clin Calcium; 2004 Jan; 14(1):39-44. PubMed ID: 15576952
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The relationship between the abnormalities in electroencephalogram and blood levels of parathyroid hormone in dialysis patients.
    Goldstein DA; Feinstein EI; Chui LA; Pattabhiraman R; Massry SG
    J Clin Endocrinol Metab; 1980 Jul; 51(1):130-4. PubMed ID: 6892917
    [No Abstract]   [Full Text] [Related]  

  • 78. Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis.
    Grzegorzewska AE; Leander M
    Adv Perit Dial; 2001; 17():10-4. PubMed ID: 11510253
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.
    Yan H; Sharma J; Weber CJ; Guyton RA; Perez S; Thourani VH
    Surgery; 2011 Dec; 150(6):1095-101. PubMed ID: 22136827
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.
    Nakanishi S; Kazama JJ; Nii-Kono T; Omori K; Yamashita T; Fukumoto S; Gejyo F; Shigematsu T; Fukagawa M
    Kidney Int; 2005 Mar; 67(3):1171-8. PubMed ID: 15698459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.